You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Lymphoma, Mantle-Cell

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Crosstalk Between Mucosal-Associated Invariant T Cells and Gut

Recruiting
  • Type1diabetes
  • MAIT cells analysis
  • +4 more
  • Antony, France
  • +1 more
Aug 2, 2022

Lymphoproliferative Disorder, HHV-8, Malignancy Trial run by the National Cancer Institute (NCI) (Etoposide, Interferon-alpha,

Active, not recruiting
  • Lymphoproliferative Disorder
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022

Lung Cancer Trial in Worldwide (Nivolumab, Ipilimumab, Placebo)

Completed
Has Results
  • Lung Cancer
  • Nivolumab
  • +2 more
  • Sacramento, California
  • +195 more
Jan 25, 2022

Stratification for Hospital-diagnosed Advanced Lung Cancer

Not yet recruiting
  • Lung Cancer
    • (no location specified)
    Feb 1, 2023

    Head and Neck Tumor Trial in Milwaukee (50 Gy Radiation Therapy, 55 Gy Radiation Therapy, 60 Gy Radiation Therapy)

    Recruiting
    • Head and Neck Neoplasm
    • 50 Gy Radiation Therapy
    • +3 more
    • Milwaukee, Wisconsin
      Froedtert & Medical College of Wisconsin
    Apr 21, 2022

    Limited Stage Small Cell Lung Cancer Trial in Beijing (Durvalumab)

    Recruiting
    • Limited Stage Small Cell Lung Cancer
    • Beijing, China
      Beijing Haidian Hospital
    Sep 1, 2021

    Are Mast Cells Involved in Autoinflammatory Diseases

    Not yet recruiting
    • Autoinflammatory Disease
    • +5 more
      • Paris, France
        Service de Médecine Interne
      Mar 22, 2022

      Mouth Tumors, Carcinoma, Squamous Cell Trial in Shanghai (drug, procedure, radiation)

      Recruiting
      • Mouth Neoplasms
      • Carcinoma, Squamous Cell
      • TPF group
      • +2 more
      • Shanghai, Shanghai, China
        Ninth People's Hospital, Shanghai Jiao Tong University School of
      Oct 5, 2022

      Recurrent Head Neck Cancer, Head Neck Cancer, Head and Neck Tumors Trial in Cincinnati (Durvalumab, Cetuximab)

      Active, not recruiting
      • Recurrent Head and Neck Cancer
      • +3 more
      • Cincinnati, Ohio
        UC Health
      Oct 3, 2022

      Anemia, Sickle Cell Trial in Nice (Kidney function assessment)

      Not yet recruiting
      • Anemia, Sickle Cell
      • Kidney function assessment
      • Nice, France
        CHU de Nice
      Jan 26, 2022

      Idiopathic Pulmonary Fibrosis, Acute Fatal Form Trial in United States (Autoantibody Reductive Therapy, Treatment as Usual

      Recruiting
      • Idiopathic Pulmonary Fibrosis, Acute Fatal Form
      • Autoantibody Reductive Therapy
      • Treatment as Usual (TAU)
      • Birmingham, Alabama
      • +6 more
      Sep 5, 2022

      Renal Cell Carcinoma Trial in Rome (donor FMT, Placebo FMT)

      Recruiting
      • Renal Cell Carcinoma
      • donor FMT
      • Placebo FMT
      • Rome, Italy
      • +1 more
      Jul 26, 2022

      Periodontal Inflammation, Periodontal Diseases Trial in Chieti (Vegan/vegetarian diet, Omnivorous diet)

      Recruiting
      • Periodontal Inflammation
      • Periodontal Diseases
      • Vegan/vegetarian diet
      • Omnivorous diet
      • Chieti, CH, Italy
        G. D'Annunzio University
      May 16, 2023

      Lesion With Known or Suspected F-choline Uptake Trial in Montréal (F-choline intravenous injection)

      Recruiting
      • Lesion With Known or Suspected F-choline Uptake
      • F-choline intravenous injection
      • Montréal, Quebec, Canada
        Centre Hospitalier de l'université de Montréal
      Dec 6, 2022

      Multiple Myeloma Trial in United States (Isatuximab, Carfilzomib, Dexamethasone)

      Recruiting
      • Multiple Myeloma
      • Isatuximab
      • +2 more
      • San Francisco, California
      • +3 more
      Dec 24, 2022

      Hematologic Malignancy, Haplo-identical Stem Cell Transplantation Trial (CD45RAneg cells, prepared from mononuclear cell

      Not yet recruiting
      • Hematologic Malignancy
      • Haplo-identical Stem Cell Transplantation
      • CD45RAneg cells, prepared from mononuclear cell leukapheresis by CliniMACS® technology
      • (no location specified)
      Oct 1, 2021

      Sickle Cell Disease Trial in United States (Patient-Specific Protocol, Weight-based Protocol, Morphine)

      Terminated
      • Sickle Cell Disease
      • Patient-Specific Protocol
      • +3 more
      • Baltimore, Maryland
      • +5 more
      May 24, 2022

      Improvement of Fatigue Symptoms in Iron Deficiency Anemia With

      Not yet recruiting
      • Anemia
      • +3 more
      • Fatigue
      • (no location specified)
      May 26, 2022

      Hiatal Hernia and Pulmonary Involvement

      Active, not recruiting
      • Hiatal Hernia
      • Interstitial Lung Disease
      • Blood Collection
      • Bronchoscopy
      • Charlottesville, Virginia
        University of Virginia
      Jan 27, 2023

      Advanced or Metastatic Solid Tumors, NSCLC Trial (NC318, Pemetrexed/Carboplatin, Nab paclitaxel/Carboplatin)

      Withdrawn
      • Advanced or Metastatic Solid Tumors
      • Non-Small Cell Lung Cancer
      • (no location specified)
      Aug 11, 2021

      PreDiabetes, Type 2 Diabetes Trial in Johor Bahru (Dipeptidyl-Peptidase IV Inhibitors)

      Completed
      • PreDiabetes
      • Type 2 Diabetes
      • Dipeptidyl-Peptidase IV Inhibitors
      • Johor Bahru, Johor, Malaysia
        Hospital Sultan Ismail
      Mar 13, 2022

      NSCLC Trial (disease self-management application)

      Not yet recruiting
      • Non-small Cell Lung Cancer
      • disease self-management application
      • (no location specified)
      Nov 9, 2022

      Basal Cell Carcinoma Trial in Boise (Topical Ascorbic Acid)

      Completed
      • Basal Cell Carcinoma
      • Topical Ascorbic Acid
      • Boise, Idaho
        Center for Biomedical Research,Inc.
      Oct 26, 2021

      Medication Compliance Trial in Durham (Smartphone App, Tailored education)

      Completed
      • Medication Compliance
      • Smartphone App
      • Tailored education
      • Durham, North Carolina
        Duke University
      Feb 15, 2022

      Sickle Cell Disease Trial in France (pediatric-adult care transition program)

      Recruiting
      • Sickle Cell Disease
      • pediatric-adult care transition program
      • Fort-de-France-La Martinique, La Martinique, France
      • +7 more
      Apr 14, 2022